Panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.

Authors

null

Eudocia Quant Lee

Dana-Farber Cancer Institute, Boston, MA

Eudocia Quant Lee , David A. Reardon , David Schiff , Jan Drappatz , Alona Muzikansky , Sean Aaron Grimm , Andrew David Norden , Lakshmi Nayak , Rameen Beroukhim , Mikael L. Rinne , Andrew S. Chi , Tracy Batchelor , Kelly Hempfling , Christine Sceppa McCluskey , Katrina H. Smith , Sarah C. Gaffey , Brendan Wrigley , Jeffrey J. Raizer , Patrick Y. Wen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

NCT00859222

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 2020)

DOI

10.1200/jco.2014.32.15_suppl.2020

Abstract #

2020

Poster Bd #

10

Abstract Disclosures

Similar Posters

First Author: Eudocia Quant Lee

First Author: Manmeet Singh Ahluwalia

First Author: Jaleh Fallah